Literature DB >> 3591743

Disseminated Merkel cell tumor. Treatment with systemic chemotherapy.

W W Grosh, L Giannone, K R Hande, D H Johnson.   

Abstract

Four patients with disseminated Merkel cell tumors were treated with cyclophosphamide (C), doxorubicin (A), and vincristine (V). Two partial responses (PR) were noted and in one case disease remained stable. One of the patients who achieved a PR achieved a second PR when treated with VP-16 (E) and cis-platin (P) after progressive disease developed. Systemic chemotherapy appears capable of inducing objective responses in some patients with disseminated Merkel cell tumors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591743     DOI: 10.1097/00000421-198706000-00011

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

1.  Response of metastatic adenoid cystic carcinoma and Merkel cell tumor to high-dose melphalan with autologous bone marrow transplantation.

Authors:  W J Slichenmyer; C F LeMaistre; D D Von Hoff
Journal:  Invest New Drugs       Date:  1992-04       Impact factor: 3.850

2.  Clinical emergence of neurometastatic merkel cell carcinoma: a surgical case series and literature review.

Authors:  Thomasina L Bailey; Maxwell A Fung; Regina Gandour-Edwards; William G Ellis; Rudolph J Schrot
Journal:  J Neurooncol       Date:  2010-07-29       Impact factor: 4.130

Review 3.  Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.

Authors:  Paul Nghiem; Howard L Kaufman; Murtuza Bharmal; Lisa Mahnke; Hemant Phatak; Jürgen C Becker
Journal:  Future Oncol       Date:  2017-03-28       Impact factor: 3.404

4.  Merkel Cell Carcinoma with Distant Metastasis to the Clivus Causing Symptoms Mimicking Tolosa-Hunt Syndrome: A Case Report and Literature Review.

Authors:  Kwo Wei David Ho; Peter A Drew; Miguel Chuquilin
Journal:  Front Neurol       Date:  2017-08-18       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.